General Cardiology

Medtronic Inc. announced the first U.S. implants in the CoreValve Evolut R Clinical Study, which will evaluate  the safety and effectiveness of the new Medtronic CoreValve Evolut R System.

TCT 2014, late breaking trials, late breaking presentations

Transcatheter Cardiovascular Therapeutics (TCT) has announced the late-breaking trial presentations at TCT 2014, Sept. 13-17.

September 9, 2014 — Use of a quadripolar left ventricular (LV) lead instead of a bipolar option during cardiac resynchronization therapy (CRT) can decrease complications at six months, according to preliminary hot line results presented at the 201...

August 21, 2014 — Efforts over the past decade to improve the quality of care for cardiovascular disease patients and increase the use of evidence-based treatments have led to a significant drop in the rate of hospitalizations and deaths, accordin...

Medtronic U.S. Implants Clinical Study Recapturable CoreValve Evolut R
Medtronic Inc. announced the first U.S. implants in the CoreValve Evolut R Clinical Study, which will evaluate  the safety and effectiveness of the new...
September 11, 2014 — Patients who rely on pacemakers and defibrillators to maintain a normal heart rhythm run the risk of serious health complications if they...
Medtronic AdaptResponse Global Clinical Trial Cardiac Resynchronization Therapy
Medtronic Inc. announced the first implants in a clinical trial that will compare patient and healthcare system outcomes — including patient...
Transcatheter Cardiovascular Therapeutics (TCT) has announced the late-breaking trial presentations at TCT 2014, Sept. 13-17.
TeleRehab VersaCare 2.1 Windows 7 The ScottCare Corp. Cardiac Rehabilitation
TeleRehab VersaCare 2.1 is the industry’s first Windows 7-based cardiopulmonary rehab telemetry system and includes direct integration with
Innovo is a rechargeable digital transmitter for the company’s VersaCare multi-parameter telemetry solution serving...
BlipCare presented the world's first Wi-Fi blood pressure monitor on international crowd funding site Indiegogo in December 2012. The...

Articles

Medtronic U.S. Implants Clinical Study Recapturable CoreValve Evolut R
Medtronic Inc. announced the first U.S. implants in the CoreValve Evolut R Clinical Study, which will evaluate  the safety and effectiveness of the new...
September 9, 2014 — Use of a quadripolar left ventricular (LV) lead instead of a bipolar option during cardiac resynchronization therapy (CRT) can decrease...
Covidien TurboHawk Clinical Study Directional Atherectomy Effective PAD Therapy
Directional atherectomy is safe and effective as a frontline therapy for the treatment of peripheral arterial disease (PAD), according to a landmark Covidien...
Directional atherectomy is safe and effective as a frontline therapy for the treatment of peripheral arterial disease (PAD), according to a landmark Covidien...

Video Center

As technology continues to advance for all diagnostic imaging modalities, it sometimes reminds me...
1 week 4 days ago
The Society of Cardiovascular Computed Tomography (SCCT) annual meeting July 10-13 in San Diego...
7 weeks 2 days ago
A big fly in the ointment for widespread adoption of many new technologies is cost. In today’s cost...
9 weeks 4 days ago
This webinar explained the benefits of better access, productivity and revenue cycle efficiency in a modern cardiovascular information system (CVIS...
The webinar "PET/CT: A New Frontier" discusses potential benefits of digital relative to analog PET/CT. The session will discuss how digital PET can improve...
Centricity Cardio Enterprise, Cardiac PACS, Cardio PACS, CVIS
This webinar demonstrates the Centricity Cardio Enterprise Solution (CCE), a solution that can help cardiology departments and hospital administrators to...

Comparison Charts

Sorry there is no data available